Obstetricians and gynecologists from Columbia and Weill Cornell Medicine are leaders in advancing the health and well-being of women and delivering personal, compassionate, and high-quality care throughout their life cycle. Their research initiatives meet the needs of all women with a focus on improving clinical outcomes, reducing maternal mortality, and facilitating patient access to care.
Women's Health (OB/GYN)
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
